MedTrace Logo

A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

NCT07171164 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2025-09-30

No results posted yet for this study

Summary

In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).

Conditions

  • Older Adults Without Any Specific Clinical Condition
  • Social Networks
  • RSV Immunization
  • Vaccine Uptake

Interventions

BEHAVIORAL

Motivate Aim: CHW text message reminders and counseling

Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage RSV vaccine uptake.

BEHAVIORAL

Motivate Aim: CHW text message reminders only

Participants receive text message reminders along with information about RSV and the RSV vaccine to encourage vaccine uptake, but do not receive the counseling intervention

BEHAVIORAL

Activate Aim: CHW text message reminders and counseling

Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage discussion of RSV vaccine uptake among older adults in their social networks

BEHAVIORAL

Activate Aim: CHW text message reminders only

Participants receive text message reminders along with information about RSV and the vaccine to encourage discussion of RSV vaccine uptake among older adults in their social networks, but do not receive the counseling intervention

Sponsors & Collaborators

Principal Investigators

  • Carina Marquez, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-10
Primary Completion
2028-11-30
Completion
2028-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07171164 on ClinicalTrials.gov